Chamomile (Matricaria chamomilla)

Matricaria chamomilla / recutita
Evidence Level
Moderate
2 Clinical Trials
5 Documented Benefits
3/5 Evidence Score

Chamomile is one of the most widely consumed herbal teas globally and among the oldest documented medicinal plants — appearing in ancient Egyptian, Greek, and Roman pharmacopeias. Its flower extract contains apigenin, bisabolol, and chamazulene — compounds with well-characterized anxiolytic, anti-inflammatory, antispasmodic, and sleep-promoting properties. Clinical trials now validate chamomile's traditional reputation for anxiety, insomnia, and digestive comfort.

Studied Dose 270–1,500 mg/day dried flower extract; anxiety: 500 mg–1,500 mg/day standardized extract; tea: 1–4 cups/day (1–2g dried flowers per cup); sleep: 270 mg twice daily
Active Compound Apigenin (flavonoid, GABA-A receptor modulator), alpha-bisabolol, chamazulene, and apigenin-7-glucoside — standardized extract typically 1.2% apigenin

Benefits

Generalized anxiety disorder reduction

A landmark Penn Medicine RCT demonstrated chamomile extract (1,500 mg/day) significantly reduced GAD symptom scores on the Hamilton Anxiety Rating Scale vs. placebo over 8 weeks — the first large, well-designed RCT establishing chamomile as a clinically meaningful natural anxiolytic. Long-term use (26 weeks) reduced relapse risk by 56% vs. placebo withdrawal.

Sleep quality and insomnia improvement

Multiple clinical studies confirm chamomile improves sleep quality, reduces time to fall asleep, and improves next-day functioning in adults with insomnia and sleep disturbances. Apigenin's GABA-A receptor binding produces sedative effects without the dependency or rebound insomnia of pharmaceutical sleep aids.

Digestive health and antispasmodic effects

Chamomile is one of the most used herbal remedies for GI complaints — functional dyspepsia, colic, gastritis, and IBS symptoms. Alpha-bisabolol reduces gastric inflammation, while the antispasmodic flavonoids relax intestinal smooth muscle to reduce cramping, bloating, and bowel irregularity.

Anti-inflammatory activity

Chamomile's chamazulene (formed during steam distillation) and alpha-bisabolol inhibit COX-2 and 5-LOX pathways, reducing prostaglandin and leukotriene production. Clinical studies confirm topical and oral chamomile reduces inflammatory markers — supporting use for mild inflammatory conditions.

Blood sugar regulation

A 8-week RCT showed chamomile tea (3 cups/day) significantly reduced fasting blood glucose, HbA1c, insulin, and HOMA-IR in type 2 diabetic patients vs. water control. Alpha-glucosidase inhibition and antioxidant protection of beta cells are proposed mechanisms.

Mechanism of action

1

Apigenin GABA-A receptor partial agonism

Apigenin — chamomile's primary flavonoid — binds the benzodiazepine site on GABA-A receptors as a partial agonist, enhancing inhibitory GABA neurotransmission and producing sedative-anxiolytic effects. Unlike benzodiazepines, apigenin's partial agonism produces milder effects without tolerance development or dependency risk.

2

Alpha-bisabolol anti-inflammatory and GI protective activity

Alpha-bisabolol inhibits NF-κB activation, reduces COX-2 expression, and protects gastric mucosa from irritant-induced damage. This anti-inflammatory and gastroprotective mechanism explains chamomile's efficacy for both systemic inflammation and GI-specific complaints.

3

Adenosine receptor modulation for sleep

Apigenin also binds central benzodiazepine receptors and modulates adenosine A1 receptors — contributing to sedative and sleep-promoting effects through both GABAergic and adenosinergic pathways simultaneously. This dual mechanism produces more natural sleep induction than single-pathway sleep aids.

Clinical trials

1
Chamomile Extract for Generalized Anxiety Disorder — RCT
PubMed

Randomized, double-blind, placebo-controlled trial of pharmaceutical-grade chamomile extract (1,500 mg/day) vs placebo in 179 adults with DSM-IV generalized anxiety disorder over 8-12 weeks. (Mao et al. 2016, Phytomedicine — landmark long-term GAD trial)

179 adults with GAD. Long-term (up to 38 weeks) intervention.

Chamomile significantly reduced HAM-A scores during open-label phase. In the randomized continuation phase, sustained chamomile use reduced relapse rate but did not reach statistical significance for the primary outcome (time to relapse). Generally well-tolerated; mild GI symptoms most common adverse effect. Note: this remains one of the better-quality long-term anxiety trials for an herbal intervention.

2
Chamomile Tea and Glycemic Control in T2DM — RCT
PubMed

Randomized controlled trial of chamomile tea (3 g/100 mL three times daily after meals) vs water in 64 type 2 diabetic patients for 8 weeks. Outcomes: fasting glucose, HbA1c, insulin, HOMA-IR, oxidative stress markers. (Rafraf et al. 2015, J Endocrinol Invest)

64 T2DM patients. 8-week intervention.

Chamomile tea significantly reduced fasting blood glucose, HbA1c, insulin, HOMA-IR, and increased antioxidant markers vs water control. Magnitude of HbA1c reduction modest; useful as adjunctive intervention rather than monotherapy. Note: should NOT replace prescribed diabetes medications.

Side effects and drug interactions

Common Potential side effects

Allergic reactions in individuals sensitive to Asteraceae family (ragweed, chrysanthemums, daisies) — perform patch test or start low
Drowsiness with high doses — do not drive or operate machinery when first using
Rare anaphylaxis in highly sensitive Asteraceae-allergic individuals

Important Drug interactions

CNS depressants (benzodiazepines, alcohol, opioids) — additive sedative effects via GABA-A mechanism; use cautiously
Warfarin — chamomile contains coumarin derivatives; potential additive anticoagulant effect; monitor INR
Antidiabetic medications — additive glucose-lowering; monitor blood sugar
CYP1A2 substrates — apigenin inhibits CYP1A2; potential interaction with caffeine, theophylline, clozapine

Frequently asked questions about Chamomile (Matricaria chamomilla)

What is the recommended dosage of Chamomile (Matricaria chamomilla)?

The clinically studied dose for Chamomile (Matricaria chamomilla) is 270–1,500 mg/day dried flower extract; anxiety: 500 mg–1,500 mg/day standardized extract; tea: 1–4 cups/day (1–2g dried flowers per cup); sleep: 270 mg twice daily. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Chamomile (Matricaria chamomilla) used for?

Chamomile (Matricaria chamomilla) is studied for generalized anxiety disorder reduction, sleep quality and insomnia improvement, digestive health and antispasmodic effects. A landmark Penn Medicine RCT demonstrated chamomile extract (1,500 mg/day) significantly reduced GAD symptom scores on the Hamilton Anxiety Rating Scale vs.

Are there side effects from taking Chamomile (Matricaria chamomilla)?

Reported potential side effects may include: Allergic reactions in individuals sensitive to Asteraceae family (ragweed, chrysanthemums, daisies) — perform patch test or start low Drowsiness with high doses — do not drive or operate machinery when first using Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Does Chamomile (Matricaria chamomilla) interact with medications?

Known drug interactions may include: CNS depressants (benzodiazepines, alcohol, opioids) — additive sedative effects via GABA-A mechanism; use cautiously Warfarin — chamomile contains coumarin derivatives; potential additive anticoagulant effect; monitor INR Consult a pharmacist or healthcare provider if you take prescription medications.

Is Chamomile (Matricaria chamomilla) good for sleep health?

Yes, Chamomile (Matricaria chamomilla) is researched for Sleep Health support. Multiple clinical studies confirm chamomile improves sleep quality, reduces time to fall asleep, and improves next-day functioning in adults with insomnia and sleep disturbances.